☰

Il Minn, Ph.D. - Publications

Affiliations: 
2008 Pennsylvania State University, State College, PA, United States 
Area:
Cell Biology
Tree Info Similar researchers PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Boinapally S, Lisok A, Lofland G, Minn I, Yan Y, Jiang Z, Shin MJ, Merino VF, Zheng L, Brayton C, Pomper MG, Banerjee SR. Hetero-bivalent agents targeting FAP and PSMA. European Journal of Nuclear Medicine and Molecular Imaging. PMID 35965291 DOI: 10.1007/s00259-022-05933-3  0.328
2021 Boinapally S, Ahn HH, Cheng B, Brummet M, Nam H, Gabrielson KL, Banerjee SR, Minn I, Pomper MG. A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile. Scientific Reports. 11: 7114. PMID 33782486 DOI: 10.1038/s41598-021-86551-1  0.33
2020 Datan E, Minn I, Xu P, He QL, Ahn HH, Yu B, Pomper MG, Liu JO. A Glucose-Triptolide Conjugate Selectively Targets Cancer Cells under Hypoxia. Iscience. 23: 101536. PMID 33083765 DOI: 10.1016/J.Isci.2020.101536  0.367
2020 Duan X, Liu F, Kwon H, Byun Y, Minn I, Cai X, Zhang J, Pomper MG, Yang Z, Xi Z, Yang X. (S)-3-(Carboxyformamido)-2-(3-(carboxymethyl)ureido)propanoic Acid as A Novel PSMA Targeting Scaffold for Prostate Cancer Imaging. Journal of Medicinal Chemistry. PMID 32207938 DOI: 10.1021/Acs.Jmedchem.9B02031  0.385
2020 Shen CJ, Minn I, Hobbs RF, Chen Y, Josefsson A, Brummet M, Banerjee SR, Brayton CF, Mease RC, Pomper MG, Kiess AP. Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer. Theranostics. 10: 2888-2896. PMID 32194842 DOI: 10.7150/Thno.38882  0.392
2020 Kim K, Kwon H, Bařinka C, Motlova L, Nam S, Choi D, Ha H, Nam H, Son SH, Minn I, Pomper MG, Yang X, Kutil Z, Byun Y. Novel β- and γ-amino acid derived inhibitors of prostate-specific membrane antigen. Journal of Medicinal Chemistry. PMID 32097010 DOI: 10.1021/Acs.Jmedchem.9B02022  0.324
2019 Son SH, Kwon H, Ahn HH, Nam H, Kim K, Nam S, Choi D, Ha H, Minn I, Byun Y. Design and synthesis of a novel BODIPY-labeled PSMA inhibitor. Bioorganic & Medicinal Chemistry Letters. 126894. PMID 31874825 DOI: 10.1016/J.Bmcl.2019.126894  0.428
2019 Banerjee SR, Kumar V, Lisok A, Chen J, Minn I, Brummet M, Boinapally S, Cole M, Ngen E, Wharram B, Brayton C, Hobbs RF, Pomper MG. Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31399803 DOI: 10.1007/S00259-019-04434-0  0.378
2019 Minn I, Huss DJ, Ahn HH, Chinn TM, Park A, Jones J, Brummet M, Rowe SP, Sysa-Shah P, Du Y, Levitsky HI, Pomper MG. Imaging CAR T cell therapy with PSMA-targeted positron emission tomography. Science Advances. 5: eaaw5096. PMID 31281894 DOI: 10.1126/Sciadv.Aaw5096  0.338
2019 Ray Banerjee S, Minn IL, Kumar V, Josefsson A, Lisok A, Brummet M, Chen J, Kiess A, Baidoo K, Brayton C, Mease RC, Brechbiel M, Sgouros G, Hobbs RF, Pomper MG. Preclinical evaluation of Pb-labeled low-molecular-weight compounds for targeted radiopharmaceutical therapy of prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31253744 DOI: 10.2967/Jnumed.119.229393  0.328
2019 Kim K, Kwon H, Choi D, Lim T, Minn I, Son SH, Byun Y. Design and synthesis of dye-conjugated hepsin inhibitors. Bioorganic Chemistry. 89: 102990. PMID 31136899 DOI: 10.1016/J.Bioorg.2019.102990  0.388
2018 Vaidyanathan G, Kang CM, McDougald D, Minn I, Brummet M, Pomper MG, Zalutsky MR. Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitors. Nuclear Medicine and Biology. 62: 18-30. PMID 29803076 DOI: 10.1016/J.Nucmedbio.2018.05.002  0.342
2018 Zhang HK, Chen Y, Kang J, Lisok A, Minn I, Pomper MG, Boctor EM. Prostate Specific Membrane Antigen (PSMA)-Targeted Photoacoustic Imaging of Prostate Cancer In Vivo. Journal of Biophotonics. e201800021. PMID 29653029 DOI: 10.1002/Jbio.201800021  0.422
2018 Ray Banerjee S, Song X, Yang X, Minn I, Lisok A, Chen Y, Pomper MG, C M van Zijl P, McMahon M, Chen J. Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate Cancer. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 29508450 DOI: 10.1002/Chem.201800882  0.365
2018 Chung HH, Lee JC, Minn I. Follicle-stimulating hormone receptor in gynecological cancers Molecular & Cellular Toxicology. 14: 1-7. DOI: 10.1007/S13273-018-0001-9  0.353
2016 Chen Y, Chatterjee S, Lisok A, Minn I, Pullambhatla M, Wharram B, Wang Y, Jin J, Bhujwalla ZM, Nimmagadda S, Mease RC, Pomper MG. A PSMA-targeted theranostic agent for photodynamic therapy. Journal of Photochemistry and Photobiology. B, Biology. 167: 111-116. PMID 28063300 DOI: 10.1016/J.Jphotobiol.2016.12.018  0.414
2016 Menezes ME, Das SK, Minn I, Emdad L, Wang XY, Sarkar D, Pomper MG, Fisher PB. Detecting Tumor Metastases: The Road to Therapy Starts Here. Advances in Cancer Research. 132: 1-44. PMID 27613128 DOI: 10.1016/Bs.Acr.2016.07.001  0.314
2016 He QL, Minn I, Wang Q, Xu P, Head SA, Datan E, Yu B, Pomper MG, Liu JO. Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation. Angewandte Chemie (International Ed. in English). PMID 27574181 DOI: 10.1002/Anie.201606121  0.33
2016 Minn I, Koo SM, Lee HS, Brummet M, Rowe SP, Gorin MA, Sysa-Shah P, Lewis WD, Ahn HH, Wang Y, Banerjee SR, Mease RC, Nimmagadda S, Allaf ME, Pomper MG, et al. [64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma. Oncotarget. PMID 27437764 DOI: 10.18632/Oncotarget.10602  0.33
2016 Kiess A, Minn IL, Vaidyanathan G, Hobbs RF, Josefsson A, Shen C, Brummet M, Chen Y, Choi J, Koumarianou E, Baidoo K, Brechbiel M, Mease RC, Sgouros G, Zalutsky MR, et al. (2S)-2-(3-(1-Carboxy-5-(4-[211At]astatobenzamido)pentyl)ureido)-pentanedioic acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27230930 DOI: 10.2967/Jnumed.116.174300  0.369
2016 Subedi M, Minn I, Chen J, Kim Y, Ok K, Jung YW, Pomper MG, Byun Y. Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands. European Journal of Medicinal Chemistry. 118: 208-218. PMID 27128184 DOI: 10.1016/J.Ejmech.2016.04.033  0.387
2016 Minn I, Koo SM, Lee HS, Brummet M, Rowe SP, Gorin MA, Sysa-Shah P, Lewis WD, Ahn H, Wang Y, Ray S, Mease RC, Nimmagadda S, Allaf ME, Pomper MG, et al. Abstract 4206: A dual-motif CAIX inhibitor, [64Cu]XYIMSR-06, for PET imaging of clear cell renal cell carcinoma Cancer Research. 76: 4206-4206. DOI: 10.1158/1538-7445.Am2016-4206  0.343
2016 Hobbs RF, Josefsson A, Kiess A, Minn I, Mease R, Brummet M, Vaidyanathan G, Zalutsky M, Pomper M. Application of Small-Scale (Sub-Organ and Cellular Level) Alpha-Particle Specific Dosimetry Model in Tumors and Kidneys in a Pre-Clinical Model of Metastatic Prostate Cancer Using 211At-YC-I-27, a PSMA-Targeting Ligand for Metastatic Prostate Cancer Brachytherapy. 15: S196. DOI: 10.1016/J.Brachy.2016.04.359  0.372
2015 Yang X, Minn I, Rowe SP, Banerjee SR, Gorin MA, Brummet M, Lee HS, Koo SM, Sysa-Shah P, Mease RC, Nimmagadda S, Allaf ME, Pomper MG. Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor. Oncotarget. PMID 26418876 DOI: 10.18632/Oncotarget.5254  0.336
2015 Kiess A, Minn I, Chen Y, Hobbs RF, Sgouros G, Mease RC, Pullambhatla M, Shen C, Foss C, Pomper M. Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26182968 DOI: 10.2967/Jnumed.115.155929  0.379
2015 Josefsson A, Kiess A, Minn I, Mease R, Brummet M, Baidoo K, Brechbiel M, Sgouros G, Pomper M, Hobbs R. Macro to Microdosimetric Analysis for Alpha Particle Radiopharmaceutical Therapy for [211At]YC-I-27, a PSMA-Targeting Ligand for Metastatic Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 93: S148-S149. DOI: 10.1016/J.Ijrobp.2015.07.352  0.341
2014 Bhatnagar A, Wang Y, Mease RC, Gabrielson M, Sysa P, Minn I, Green G, Simmons B, Gabrielson K, Sarkar S, Fisher PB, Pomper MG. AEG-1 promoter-mediated imaging of prostate cancer. Cancer Research. 74: 5772-81. PMID 25145668 DOI: 10.1158/0008-5472.Can-14-0018  0.391
2014 Shallal HM, Minn I, Banerjee SR, Lisok A, Mease RC, Pomper MG. Heterobivalent agents targeting PSMA and integrin-αvβ3. Bioconjugate Chemistry. 25: 393-405. PMID 24410012 DOI: 10.1021/Bc4005377  0.398
2014 Kiess A, Chen Y, Minn I, Brummet M, Pomper M. Targeted Molecular Auger Radiation Therapy for Micrometastatic Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S805-S806. DOI: 10.1016/J.Ijrobp.2014.05.2325  0.356
2012 Tsai HC, Li H, Van Neste L, Cai Y, Robert C, Rassool FV, Shin JJ, Harbom KM, Beaty R, Pappou E, Harris J, Yen RW, Ahuja N, Brock MV, Stearns V, ... ... Minn I, et al. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell. 21: 430-46. PMID 22439938 DOI: 10.1016/J.Ccr.2011.12.029  0.305
2012 Tsai H, Li H, Neste LV, Cai Y, Robert C, Rassool FV, Shin JJ, Harbom KM, Beaty R, Pappou E, Harris J, Yen RC, Ahuja N, Brock MV, Stearns V, ... ... Minn I, et al. Abstract 995: Transient low doses of DNA demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells Cancer Research. 72: 995-995. DOI: 10.1158/1538-7445.Am2012-995  0.348
2010 Tsai H, Neste LV, Li H, Cai Y, Robert C, Shin JJ, Pappou E, Yen R, Minn I, Ahuja N, Brock MV, Rassool FV, Jang Y, Sharkis SJ, Matsui W, et al. Abstract LB-88: Transient exposure to low-dose decitabine and azacytidine reprograms cancer cells to produce a prolonged antitumor response Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-88  0.33
2009 Minn IL, Rolls MM, Hanna-Rose W, Malone CJ. SUN-1 and ZYG-12, mediators of centrosome-nucleus attachment, are a functional SUN/KASH pair in Caenorhabditis elegans. Molecular Biology of the Cell. 20: 4586-95. PMID 19759181 DOI: 10.1091/Mbc.E08-10-1034  0.56
Show low-probability matches.